These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 26799258)

  • 1. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
    Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
    J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
    Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
    J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
    Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
    J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
    Horst D; Kriegl L; Engel J; Kirchner T; Jung A
    Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.
    Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D
    World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
    Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
    Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
    Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
    Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
    Jiang S; Pei L; Yang ZL; Liu G
    Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133 expression is correlated with poor prognosis in colorectal cancer.
    Kashihara H; Shimada M; Kurita N; Iwata T; Sato H; Kozo Yoshikawa ; Higashijima J; Chikakiyo M; Nishi M; Matsumoto N
    Hepatogastroenterology; 2014 Sep; 61(134):1563-7. PubMed ID: 25436343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
    Zhao P; Lu Y; Jiang X; Li X
    Cancer Sci; 2011 May; 102(5):1107-11. PubMed ID: 21276138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.
    Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K
    Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma.
    Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
    Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
    Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.
    García VM; Batlle JF; Casado E; Burgos E; de Castro J; Belda C; Barriuso J; Sánchez JJ; García-Cabezas MÁ; González-Barón M; Cejas P
    Colorectal Dis; 2011 Sep; 13(9):989-98. PubMed ID: 20718834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.
    Huang X; Sheng Y; Guan M
    Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis.
    Bellizzi A; Sebastian S; Ceglia P; Centonze M; Divella R; Manzillo EF; Azzariti A; Silvestris N; Montemurro S; Caliandro C; De Luca R; Cicero G; Rizzo S; Russo A; Quaranta M; Simone G; Paradiso A
    J Cell Physiol; 2013 Feb; 228(2):408-15. PubMed ID: 22740326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.